Electronic Weight Loss Implant Approved By USDA
There are pills and surgeries that are all vying for consumers' attentions as the weight loss solution, and one more is about to become available to Americans looking for a way out from their obesity.
Weight loss is a big market. There are pills and surgeries that are all vying for consumers' attentions as the weight loss solution, and one more is about to become available to Americans looking for a way out from their obesity.
Clare Wilson from New Scientist wrote an article about the Maestro Rechargeable System that was approved by the US Food and Drug Administration. The device will be available to those who have a body mass index (BMI) over 35 points or have a weight-related condition.
The device works by blocking the signals from the vagus nerve, which is the line of communication between the brain and several major organs. However, surgeons would attach electrodes only to the part of the nerve that talks to the stomach.
After undergoing a year-long study, which took 239 participants with BMIs ranging from 35 to 45 and one or more obesity-related condition, it led participants to lose, on average, 9 percent of their body weight. However, in a placebo trial participants lost an average of 6 percent of their body weight--a curious note. Of course, the purpose of the study was to determine if the treatment was effective as well as safe.
In their report the researchers wrote:
“The treatment was well tolerated, having met the primary safety objective.”
“The adverse events more frequent in the vagal nerve block group were heartburn or dyspepsia and abdominal pain attributed to therapy; all were reported as mild or moderate in severity.”
Nick Finer of University College Hospital in London, spoke to New Scientist, pointing out that gastric bypass surgery would be a better route than this device, citing that it leads to greater loss and it's safe. But surgeon Scott Shikora, speaking on behalf of the device's manufacturer, EnteroMedics, told New Scientist that there's hesitation among patients to have such invasive surgery:
"A lot of patients don't want the operations we are currently performing because they view them as being too risky or too radical.”
The company has yet to release it long-term study, which was conducted on fewer patients. But Shikora said the study suggests that people's weight loss reached its pique after a year of use and participants maintained that weight for at least five years. However, there's still this placebo effect to consider. Perhaps it's not the device that's the major cause of the weight loss, but the thought that there's a support system in place. What do you think?
Read more at New Scientist
Photo Credit: Vic/Flickr
Malcolm Gladwell teaches "Get over yourself and get to work" for Big Think Edge.
- Learn to recognize failure and know the big difference between panicking and choking.
- At Big Think Edge, Malcolm Gladwell teaches how to check your inner critic and get clear on what failure is.
- Subscribe to Big Think Edge before we launch on March 30 to get 20% off monthly and annual memberships.
Big tech is making its opening moves into the health care scene, but its focus on tech-savvy millennials may miss the mark.
- Companies like Apple, Amazon, and Google have been busy investing in health care companies, developing new apps, and hiring health professionals for new business ventures.
- Their current focus appears to be on tech-savvy millennials, but the bulk of health care expenditures goes to the elderly.
- Big tech should look to integrating its most promising health care devise, the smartphone, more thoroughly into health care.
Turns out pushups are more telling than treadmill tests when it comes to cardiovascular health.
- Men who can perform 40 pushups in one minute are 96 percent less likely to have cardiovascular disease than those who do less than 10.
- The Harvard study focused on over 1,100 firefighters with a median age of 39.
- The exact results might not be applicable to men of other age groups or to women, researchers warn.
Here's why universal basic income will hurt the 99%, and make the 1% even richer.
- Universal basic income is a band-aid solution that will not solve wealth inequality, says Rushkoff.
- Funneling money to the 99% perpetuates their roles as consumers, pumping money straight back up to the 1% at the top of the pyramid.
- Rushkoff suggests universal basic assets instead, so that the people at the bottom of the pyramid can own some means of production and participate in the profits of mega-rich companies.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.